NEW YORK--(BUSINESS WIRE)--July 25, 2006--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or “The Company”) (NASDAQ: OMRI - News), a commercial-stage biopharmaceutical company that develops and markets biosurgical and passive immunotherapy products, will announce financial results for the second quarter ended June 30, 2006 after the close of U.S. financial markets on Tuesday, August 8, 2006. An accompanying conference call to discuss the results will be held the same day at 5:00 p.m. EDT; 2:00 p.m. PDT. To access the live telephonic broadcast, U.S. callers should dial (800) 819-9193; international callers may dial (913) 981-4911. A live audio webcast of the call will be available at the Company’s website at www.omrix.com. Participants are urged to log on to the website 15 minutes prior to the scheduled start time to download and install any necessary software.
